Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
We provide a chemotherapy treatment service that offers you both choice and flexibility. Chemotherapy is the use of cytotoxic (anti-cancer) drugs to destroy cancer cells in the body by disrupting the cancer cells and preventing them from growing and dividing.
Dr Sanjay Raj’s special interest is the treatment of breast cancer with chemotherapy, radiotherapy and biological and endocrine treatments. He also has an interest in new radiotherapy techniques including IMRT and image guided radiotherapy.
Dr Raj qualified in 1998 at UCL, Royal Free Hospital. He completed his specialist Oncology Training at Adddenbrooke's Hospital Cambridge and was awarded his FRCR in 2007. Dr Raj has been a Consultant Oncologist in the Wessex region since 2009. He is a principal investigator on over ten National Cancer Research Institute trials, including the IMPORT HIGH trial, TARGIT and FAST-Forward. He is also principal investigator of trials studying systemic and biological agents, including the PARTNER, ARTemis and SafeHER studies. Dr Raj is a Consultant Clinical Oncologist, Southampton University Hospitals NHS Trust in addition to a consultant at Rutherford Cancer Centre Thames Valley.
Proton Beam Therapy
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.